Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

developmental and epileptic encephalopathy, 4 News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study characterizes the phenotypic and transcriptomic features of biallelic RNU2-2 mutations associated with developmental and epileptic encephalopathy. This research enhances understanding of the disease mechanisms and may inform future therapeutic strategies.

A study identifies a de novo NR2F1 c.330 C>A variant linked to Bosch-Boonstra-Schaaf optic atrophy syndrome, which presents with early-onset developmental and epileptic encephalopathy. This discovery enhances understanding of the genetic underpinnings of these conditions.

Recent research utilizing optical genome mapping has uncovered previously undetected causal variants in early-onset developmental epileptic encephalopathies. This advancement could enhance diagnostic accuracy and treatment strategies for affected patients.

Not rare diseases news,news about your rare disease.

Earlier

A recent study characterizes the phenotypic and transcriptomic features of biallelic RNU2-2 mutations associated with developmental and epileptic encephalopathy. This research enhances understanding of the disease mechanisms and may inform future therapeutic strategies.

A study identifies a de novo NR2F1 c.330 C>A variant linked to Bosch-Boonstra-Schaaf optic atrophy syndrome, which presents with early-onset developmental and epileptic encephalopathy. This discovery enhances understanding of the genetic underpinnings of these conditions.

Recent research utilizing optical genome mapping has uncovered previously undetected causal variants in early-onset developmental epileptic encephalopathies. This advancement could enhance diagnostic accuracy and treatment strategies for affected patients.

Not rare diseases news,
news about your rare disease.